Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea

Clinical and molecular hepatology

Volumn 21, Issue 4, 2015, Pages 358-364

  Cho, Yuri ^a   Cho, Eun Ju ^a   Lee, Jeong Hoon ^a   Yu, Su Jong ^a   Yoon, Jung Hwan ^a   Kim, Yoon Jun ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Chronic hepatitis C; Direct acting antiviral; Korea

Indexed keywords

ANTIVIRUS AGENT; HEMOGLOBIN; RIBAVIRIN; SOFOSBUVIR; VIRUS RNA;

ADULT; AGED; BLOOD; COMBINATION DRUG THERAPY; COMPLICATION; FATIGUE; FEMALE; GENETICS; GENOTYPE; HEADACHE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMAN; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; SOUTH KOREA; TREATMENT OUTCOME; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FATIGUE; FEMALE; GENOTYPE; HEADACHE; HEMOGLOBINS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RIBAVIRIN; RNA, VIRAL; SOFOSBUVIR; TREATMENT OUTCOME;

EID: 85050578259     PISSN: None     EISSN: 2287285X     Source Type: Journal    
DOI: 10.3350/cmh.2015.21.4.358     Document Type: Article

References (0)